Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease

23Citations
Citations of this article
49Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Up to 40% of patients with gastroesophageal reflux disease (GERD) report persistent symptoms despite proton pump inhibitor (PPI) therapy. This review outlines the evidence for surgical and endoscopic therapies for the treatment of PPI nonresponsive GERD. A literature search for GERD therapies from 2005 to 2015 in PubMed, EMBASE, Cochrane Central Register of Controlled Trials, and the Cochrane Database of Systematic Reviews identified 2928 unique citations. Of those, 45 unique articles specific to surgical and endoscopic therapies for PPI nonresponsive GERD were reviewed. Laparoscopic fundoplication (n = 19) provides symptomatic and physiologic relief out to 10 years, though efficacy wanes with time. Magnetic sphincter augmentation (n = 6) and transoral incisionless fundoplication (n = 9) improve symptoms in PPI nonresponders and may offer fewer side effects than fundoplication, though long-term follow-up is lacking. Radiofrequency energy delivery (n = 8) has insufficient evidence for routine use in treating PPI nonresponsive GERD. Electrical stimulator implantation (n = 1) and endoscopic mucosal surgery (n = 2) are newer therapies under evaluation for the treatment of GERD. Laparoscopic fundoplication remains the most proven therapeutic approach. Newer antireflux procedures such as magnetic sphincter augmentation and transoral incisionless fundoplication offer alternatives with varying degrees of success, durability, and side effect profiles that may better suit individual patients. Larger head-to-head comparison trials are needed to better characterize the difference in symptom response and side effect profiles.

References Powered by Scopus

Multivariate Analysis of Factors Predicting Outcome After Laparoscopic Nissen Fundoplication

357Citations
N/AReaders
Get full text

Diagnosis and management of patients with reflux symptoms refractory to proton pump inhibitors

292Citations
N/AReaders
Get full text

Effect of the GABA<inf>B</inf> agonist baclofen in patients with symptoms and duodeno-gastro-oesophageal reflux refractory to proton pump inhibitors

274Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Randomized trial of medical versus surgical treatment for refractory heartburn

186Citations
N/AReaders
Get full text

Management options for patients with GERD and persistent symptoms on proton pump inhibitors: recommendations from an expert panel

79Citations
N/AReaders
Get full text

Are the persistent symptoms to proton pump inhibitor therapy due to refractory gastroesophageal reflux disease or to other disorders?

19Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Hillman, L., Yadlapati, R., Whitsett, M., Thuluvath, A. J., Berendsen, M. A., & Pandolfino, J. E. (2017, September 1). Review of antireflux procedures for proton pump inhibitor nonresponsive gastroesophageal reflux disease. Diseases of the Esophagus. Oxford University Press. https://doi.org/10.1093/dote/dox054

Readers' Seniority

Tooltip

Researcher 12

50%

PhD / Post grad / Masters / Doc 7

29%

Professor / Associate Prof. 4

17%

Lecturer / Post doc 1

4%

Readers' Discipline

Tooltip

Medicine and Dentistry 22

85%

Environmental Science 2

8%

Nursing and Health Professions 1

4%

Mathematics 1

4%

Save time finding and organizing research with Mendeley

Sign up for free